GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » GemPharmatech Co Ltd (SHSE:688046) » Definitions » Loans Receivable

GemPharmatech Co (SHSE:688046) Loans Receivable : ¥0.0 Mil (As of Jun. 2024)


View and export this data going back to 2022. Start your Free Trial

What is GemPharmatech Co Loans Receivable?

GemPharmatech Co's Loans Receivable for the quarter that ended in Jun. 2024 was ¥0.0 Mil.


GemPharmatech Co Loans Receivable Historical Data

The historical data trend for GemPharmatech Co's Loans Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GemPharmatech Co Loans Receivable Chart

GemPharmatech Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Loans Receivable
Get a 7-Day Free Trial - - - - -

GemPharmatech Co Quarterly Data
Dec18 Dec19 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Loans Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

GemPharmatech Co Loans Receivable Calculation

Loans Receivable are the funds that a company has lent but have not yet been repaid.


GemPharmatech Co Loans Receivable Related Terms

Thank you for viewing the detailed overview of GemPharmatech Co's Loans Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


GemPharmatech Co Business Description

Traded in Other Exchanges
N/A
Address
No. 12, Xuefu Road, Jiangbei New District, Jiangsu Province, Nanjing, CHN, 210032
GemPharmatech Co Ltd is a provider of?genetically engineered mouse?models?and services to global preclinical research and development communities. It specializes in developing animal models using cutting edge gene-editing technologies with a large collection of?cKO/KO (conditional knockout/knockout) mice, humanized mice, immunodeficient mice, and germ-free mice.

GemPharmatech Co Headlines

No Headlines